SCHEDULE: Morgan Stanley Exits Terns Pharmaceuticals Position

Morgan Stanley has filed an amendment indicating it no longer beneficially owns more than five percent of Terns Pharmaceuticals, Inc. common stock.

Summary

• Morgan Stanley filed an Amendment No. 2 to its Schedule 13G regarding Terns Pharmaceuticals, Inc.
• The filing confirms that as of May 31, 2026, Morgan Stanley has ceased to be a beneficial owner of more than five percent of the company's common stock.
• The reported beneficial ownership is now 0.0%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure reflecting a change in institutional portfolio composition rather than a fundamental shift in the company's business operations.

Positives

• The filing indicates a clean exit of a major institutional position, which removes potential overhang from future block sales by this specific entity.

Negatives

• The loss of a major institutional shareholder like Morgan Stanley may be perceived by some market participants as a lack of long-term conviction in the issuer's current trajectory.

Risks

• Potential negative market sentiment resulting from the divestment of a significant institutional holder.

Future Outlook

Not applicable as this is a notice of cessation of beneficial ownership.

Industry Context

StockSavvy.ai notes that institutional divestment filings are common in the biotech sector as funds rebalance portfolios or reach the end of their investment thesis for specific clinical-stage companies.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investors dropping below the 5% ownership threshold.

Stakeholder Impact

• Shareholders may observe minor volatility as the market adjusts to the change in institutional ownership structure.

Next Steps

• No further action required by the issuer regarding this specific filing.

Key Dates

Keywords

Terns Pharmaceuticals, Morgan Stanley, Schedule 13G, Institutional Ownership, Divestment, Common Stock